Src Family Tyrosine Kinases in Intestinal Homeostasis, Regeneration and Tumorigenesis.

Src cancer therapy cell signalling colon cancer intestinal epithelium tyrosine kinase

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
23 Jul 2020
Historique:
received: 17 06 2020
revised: 18 07 2020
accepted: 19 07 2020
entrez: 29 7 2020
pubmed: 29 7 2020
medline: 29 7 2020
Statut: epublish

Résumé

Src, originally identified as an oncogene, is a membrane-anchored tyrosine kinase and the Src family kinase (SFK) prototype. SFKs regulate the signalling induced by a wide range of cell surface receptors leading to epithelial cell growth and adhesion. In the intestine, the SFK members Src, Fyn and Yes regulate epithelial cell proliferation and migration during tissue regeneration and transformation, thus implicating conserved and specific functions. In patients with colon cancer, SFK activity is a marker of poor clinical prognosis and a potent driver of metastasis formation. These tumorigenic activities are linked to SFK capacity to promote the dissemination and tumour-initiating capacities of epithelial tumour cells. However, it is unclear how SFKs promote colon tumour formation and metastatic progression because SFK-encoding genes are unfrequently mutated in human cancer. Here, we review recent findings on SFK signalling during intestinal homeostasis, regeneration and tumorigenesis. We also describe the key nongenetic mechanisms underlying SFK tumour activities in colorectal cancer, and discuss how these mechanisms could be exploited in therapeutic strategies to target SFK signalling in metastatic colon cancer.

Identifiants

pubmed: 32717909
pii: cancers12082014
doi: 10.3390/cancers12082014
pmc: PMC7464719
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : ligue nationale contre le cancer
ID : labelllisation LIGUE 2020
Organisme : Institut National Du Cancer
ID : INCa-DGOS-Inserm 6045

Références

Science. 2014 Jun 13;344(6189):1242281
pubmed: 24926024
Nat Commun. 2019 Nov 13;10(1):5139
pubmed: 31723138
EMBO J. 2006 May 3;25(9):1895-905
pubmed: 16619028
Clin Cancer Res. 2017 Aug 1;23(15):4146-4154
pubmed: 28280091
Cancer Sci. 2016 Jul;107(7):972-80
pubmed: 27116701
Nat Commun. 2018 Oct 30;9(1):4522
pubmed: 30375386
Nature. 2015 Mar 5;519(7541):57-62
pubmed: 25731159
Science. 1995 Sep 15;269(5230):1567-9
pubmed: 7545311
Mol Cell Proteomics. 2012 Dec;11(12):1937-50
pubmed: 23023324
J Cell Biol. 2004 Oct 25;167(2):223-9
pubmed: 15504909
Nature. 2014 Jun 5;510(7503):167-71
pubmed: 24739973
EMBO J. 2011 Jun 24;30(15):3186-99
pubmed: 21701559
Cancer Res. 2018 Jun 1;78(11):2825-2838
pubmed: 29531159
Leukemia. 2009 Mar;23(3):477-85
pubmed: 19039322
Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14938-43
pubmed: 21873224
Cell Stem Cell. 2014 Mar 6;14(3):306-21
pubmed: 24607405
Structure. 2005 Jun;13(6):861-71
pubmed: 15939018
Immunity. 2001 Sep;15(3):457-66
pubmed: 11567635
J Biol Chem. 2001 Sep 14;276(37):35185-93
pubmed: 11448952
Eur J Med Chem. 2011 Oct;46(10):4853-8
pubmed: 21852023
Nat Rev Mol Cell Biol. 2011 Jun 23;12(7):413-26
pubmed: 21697900
PLoS Genet. 2017 Nov 6;13(11):e1007091
pubmed: 29108021
Cell Stem Cell. 2012 Oct 5;11(4):452-60
pubmed: 23040474
Inflamm Bowel Dis. 2008 Mar;14(3):310-7
pubmed: 18069675
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
Sci Adv. 2019 Feb 20;5(2):eaav2437
pubmed: 30801016
Int J Mol Sci. 2017 Apr 12;18(4):
pubmed: 28417908
J Immunol. 2014 Nov 15;193(10):5249-63
pubmed: 25339668
Am J Cancer Res. 2015 May 15;5(6):1972-87
pubmed: 26269757
Mol Cell Biol. 2000 May;20(10):3396-406
pubmed: 10779329
J Leukoc Biol. 2015 Jun;97(6):1089-99
pubmed: 25877924
PLoS Biol. 2016 Mar 04;14(3):e1002401
pubmed: 26942442
Nat Rev Clin Oncol. 2020 Jan;17(1):11-32
pubmed: 31289352
Mol Cell Biol. 2006 Apr;26(7):2479-89
pubmed: 16537894
Clin Cancer Res. 2002 Jul;8(7):2430-6
pubmed: 12114449
Cell Stem Cell. 2009 Feb 6;4(2):124-7
pubmed: 19200801
Mol Cell Biol. 2016 Oct 28;36(22):2811-2823
pubmed: 27550814
Blood. 2007 Dec 1;110(12):4055-63
pubmed: 17720881
Cell. 2014 Nov 6;159(4):844-56
pubmed: 25417160
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1643-1648
pubmed: 28130546
J Cell Biol. 2018 Sep 3;217(9):3071-3089
pubmed: 29954829
Nat Commun. 2014;5:3159
pubmed: 24457997
Nat Commun. 2018 Oct 19;9(1):4351
pubmed: 30341294
Cancer Cell. 2009 Jul 7;16(1):67-78
pubmed: 19573813
Cancer Sci. 2020 Feb;111(2):418-428
pubmed: 31799727
Mucosal Immunol. 2014 Mar;7(2):405-16
pubmed: 24045577
Nature. 2012 Nov 8;491(7423):254-8
pubmed: 23034650
Nature. 2016 Jan 21;529(7586):298-306
pubmed: 26791720
Cancer Res. 2009 May 1;69(9):3842-9
pubmed: 19383922
J Cell Biol. 2008 Aug 11;182(3):603-14
pubmed: 18695048
Nature. 2009 Jan 29;457(7229):608-11
pubmed: 19092804
Curr Biol. 1998 Aug 27;8(17):975-8
pubmed: 9742401
Oncogene. 2004 Oct 18;23(48):7918-27
pubmed: 15489910
Structure. 2017 Apr 4;25(4):630-640.e4
pubmed: 28319009
Structure. 2018 Apr 3;26(4):545-554.e4
pubmed: 29503074
Exp Mol Pathol. 2007 Oct;83(2):207-15
pubmed: 17599831
Gastroenterology. 2019 Mar;156(4):1066-1081.e16
pubmed: 30448068
Oncotarget. 2016 May 31;7(22):33111-24
pubmed: 27105527
Cell Rep. 2017 Jul 25;20(4):999-1015
pubmed: 28746882
Autophagy. 2020 Apr;16(4):735-749
pubmed: 31208298
J Clin Invest. 2014 Jan;124(1):156-68
pubmed: 24316974
Nat Rev Mol Cell Biol. 2016 Oct;17(10):611-25
pubmed: 27461391
iScience. 2019 Feb 22;12:194-203
pubmed: 30690395
Cancer Lett. 2017 Dec 1;410:32-40
pubmed: 28939028
Carcinogenesis. 2015 Jun;36(6):607-15
pubmed: 25863128
Invest New Drugs. 2015 Aug;33(4):977-84
pubmed: 26062928
BMC Cancer. 2014 Sep 10;14:660
pubmed: 25208577
Gastroenterology. 2020 May 30;:
pubmed: 32485177
Mol Cell. 2004 Feb 13;13(3):341-55
pubmed: 14967142
Nat Rev Cancer. 2015 Feb;15(2):73-79
pubmed: 25592648
Cancer Cell. 2019 Oct 14;36(4):431-443.e5
pubmed: 31543464
Immunity. 2014 Dec 18;41(6):1052-63
pubmed: 25526314
Cell Stem Cell. 2018 Jan 4;22(1):35-49.e7
pubmed: 29249464
Nat Rev Mol Cell Biol. 2001 Jun;2(6):467-75
pubmed: 11389470
Cancers (Basel). 2020 May 23;12(5):
pubmed: 32456226
Nature. 2018 Feb 22;554(7693):538-543
pubmed: 29443964
Genes Dev. 1996 Aug 1;10(15):1845-57
pubmed: 8756343
J Cell Sci. 2013 Jan 15;126(Pt 2):393-401
pubmed: 23525005
Oncogene. 2002 Nov 7;21(51):7797-807
pubmed: 12420216
Cancer Res. 2001 Feb 15;61(4):1415-20
pubmed: 11245444
Proteomics. 2015 Jan;15(2-3):232-44
pubmed: 25403792
Cell Rep. 2018 Oct 9;25(2):449-463.e4
pubmed: 30304684
Cell. 2012 Dec 21;151(7):1457-73
pubmed: 23245941
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 19;367(1602):2540-55
pubmed: 22889906
Sci Rep. 2019 Mar 1;9(1):3265
pubmed: 30824759
J Biol Chem. 2011 May 6;286(18):15698-706
pubmed: 21388951
Cell Rep. 2020 Mar 24;30(12):4235-4249.e6
pubmed: 32209481
EMBO J. 2007 Jun 20;26(12):2843-55
pubmed: 17525734
Nat Genet. 1999 Feb;21(2):187-90
pubmed: 9988270
Cell Rep. 2017 May 23;19(8):1495-1502
pubmed: 28538170
EMBO J. 1997 Oct 1;16(19):5904-13
pubmed: 9312048
Nat Commun. 2018 Nov 8;9(1):4695
pubmed: 30410020
Nat Genet. 2019 Jul;51(7):1113-1122
pubmed: 31209394
Colloids Surf B Biointerfaces. 2016 Feb 1;138:17-25
pubmed: 26638178
EMBO J. 2014 Jul 1;33(13):1474-91
pubmed: 24788409
Cancer Metastasis Rev. 2008 Mar;27(1):103-18
pubmed: 18049863
Oncogene. 2011 Feb 3;30(5):561-74
pubmed: 20956938
Mol Cell. 2008 May 23;30(4):426-36
pubmed: 18498747
J Clin Invest. 1989 Jun;83(6):2025-33
pubmed: 2498394
PLoS One. 2011 Feb 24;6(2):e17237
pubmed: 21390316
Lancet. 2014 Apr 26;383(9927):1490-1502
pubmed: 24225001
EMBO Rep. 2020 Apr 3;21(4):e48183
pubmed: 32141187
Am J Physiol Cell Physiol. 2019 Nov 1;317(5):C869-C880
pubmed: 31291143
J Leukoc Biol. 2018 Mar 30;:
pubmed: 29601097
Cell. 2003 Mar 21;112(6):859-71
pubmed: 12654251
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12495-12500
pubmed: 29109268
Nat Biotechnol. 2007 Sep;25(9):1035-44
pubmed: 17721511
Cell Chem Biol. 2019 Jun 20;26(6):842-851.e7
pubmed: 30956149
Cell Signal. 2019 Apr;56:15-22
pubmed: 30684564
Am J Cancer Res. 2019 Feb 01;9(2):449-454
pubmed: 30906642
Structure. 2015 May 5;23(5):893-902
pubmed: 25914053
Cancers (Basel). 2019 May 14;11(5):
pubmed: 31091767
Mol Cancer Res. 2017 Jun;15(6):708-713
pubmed: 28184012
Cancer Metastasis Rev. 2003 Dec;22(4):337-58
pubmed: 12884910
Oncotarget. 2017 Jul 25;8(30):48782-48793
pubmed: 27447856
Cancer Cell. 2017 Apr 10;31(4):563-575.e5
pubmed: 28399411
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Am J Cancer Res. 2012;2(4):357-71
pubmed: 22860228
Cancer Res. 2010 Jul 15;70(14):5706-16
pubmed: 20570886
Hum Pathol. 2017 Sep;67:119-125
pubmed: 28601656
Mol Cancer. 2018 Feb 19;17(1):58
pubmed: 29455648
Cancer Res. 2009 Mar 15;69(6):2279-86
pubmed: 19276381
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2358-62
pubmed: 18258742
Nature. 2014 Sep 18;513(7518):382-7
pubmed: 25043054
Oncogene. 2010 Mar 4;29(9):1303-15
pubmed: 20010872
Cancers (Basel). 2020 Jun 02;12(6):
pubmed: 32498343
Aust N Z J Med. 1976 Apr;6(2):156-7
pubmed: 1067816
Nat Rev Cancer. 2004 Jun;4(6):470-80
pubmed: 15170449
Oncogene. 2015 Apr 30;34(18):2371-84
pubmed: 24975577
Cancer Immunol Res. 2017 Feb;5(2):157-169
pubmed: 28073775
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Biol Chem. 2018 Oct 5;293(40):15524-15537
pubmed: 30135207
Nat Biotechnol. 2017 Jun;35(6):577-582
pubmed: 28459450
Cancer Cell. 2018 Jan 8;33(1):125-136.e3
pubmed: 29316426
Br J Cancer. 2014 Nov 25;111(11):2058-66
pubmed: 25290090
Immunol Rev. 2009 Nov;232(1):273-85
pubmed: 19909370
Oncogene. 2020 May;39(19):3803-3820
pubmed: 32157217
Cancer Cell. 2013 Oct 14;24(4):410-21
pubmed: 24135279
J Biol Chem. 1998 Jan 9;273(2):1052-7
pubmed: 9422768
Proc Natl Acad Sci U S A. 1990 Jan;87(2):558-62
pubmed: 2105487
Nature. 2015 Jul 9;523(7559):231-5
pubmed: 25970248
Mol Cell Biol. 1995 Feb;15(2):1102-9
pubmed: 7823926
Biochem Biophys Res Commun. 2018 Sep 26;504(1):109-114
pubmed: 30173891
Oncogene. 2010 Dec 2;29(48):6402-8
pubmed: 20956943
Nat Rev Cancer. 2017 Feb;17(2):79-92
pubmed: 28050011
Int J Biol Sci. 2012;8(10):1385-97
pubmed: 23139636
Nat Rev Clin Oncol. 2009 Oct;6(10):587-95
pubmed: 19787002
Cell. 2017 Jun 1;169(6):985-999
pubmed: 28575679
Sci Rep. 2019 Feb 21;9(1):2466
pubmed: 30792536

Auteurs

Audrey Sirvent (A)

CRBM, CNRS, University of Montpellier, Equipe labellisée Ligue Contre le Cancer, F-34000 Montpellier, France.

Rudy Mevizou (R)

CRBM, CNRS, University of Montpellier, Equipe labellisée Ligue Contre le Cancer, F-34000 Montpellier, France.

Dana Naim (D)

CRBM, CNRS, University of Montpellier, Equipe labellisée Ligue Contre le Cancer, F-34000 Montpellier, France.

Marie Lafitte (M)

CRBM, CNRS, University of Montpellier, Equipe labellisée Ligue Contre le Cancer, F-34000 Montpellier, France.

Serge Roche (S)

CRBM, CNRS, University of Montpellier, Equipe labellisée Ligue Contre le Cancer, F-34000 Montpellier, France.

Classifications MeSH